A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

Summary

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additional evidence for the potential clinical benefits of tirzepatide in this population.

Timeline

Start

2022-10-11

Primary completion

2027-10

Completion

2027-10

Publications

• Antza C, Anyfanti P, Poutachidis A, Poulis D, Belancic A, Kotsis V. Hypertension in young adults with obesity: new mechanisms and therapeutic options. Pol Arch Intern Med. 2026 Feb 26;136(2):17203. doi: 10.20452/pamw.17203. Epub 2026 Jan 23.

Drugs

Indications